
GSK vs IBN
$GSK vs $IBN head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs IBN: the quick read
- ·IBN is the larger company by market cap ($106.30B vs $103.46B).
- ·GSK has been more active on our scanner (42 vs 6 alerts in 30 days).
- ·GSK has the smaller float (2.00B vs 3.59B), which tends to mean sharper, more volatile moves.
- ·Both are unknown names, so this is a like-for-like comparison and sector news tends to move them together.
- ·GSK draws far more of our scanner's attention, 42 unusual-volume alerts in 30 days against 6, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both pay a dividend, so this is one of the few pairs here where yield is a fair tiebreaker.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and IBN on TheDesperateTrader.
- Is GSK or IBN the better stock?
- "Better" depends on your goal, and these two are not alike. IBN is the larger company by market cap ($106.30B vs $103.46B). GSK has been more active on our scanner (42 vs 6 alerts in 30 days). GSK has the smaller float (2.00B vs 3.59B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and IBN?
- The differences that matter: they are similar in size ($103.46B vs $106.30B); they trade at very different share prices ($51.98 vs $29.64); GSK sits at 58% of its 52-week range against 55% for IBN; our scanner flagged GSK 42 times in the last 30 days against 6 for IBN. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and IBN is more active right now?
- Right now GSK is at about 1.0x its normal volume and IBN is at about 0.6x, so GSK is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or IBN? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.